According to Taiwanese media reports, the number of local cases of new coronavirus pneumonia in Taiwan on the 14th approached the 50,000 mark. Psychiatrist Shen Zhengnan posted on Facebook that it will exceed 60,000 in at least one day, but the average of the whole week may not e

According to Taiwanese media reports, the number of local cases of COVID-19 in Taiwan approached the 50,000 mark on the 14th. Psychiatrist Shen Zhengnan posted on Facebook that it will exceed 60,000 in at least one day, but the average of the whole week may not exceed 60,000. The reason is that before BA.5 reaches its peak, it will infect at least 5% of the population, about 1 million, but now it is obviously still a bit far away. This is the same data as Portugal and Hong Kong. It is nearly 50,000 now, and if the curve continues to rise in another week or two, it will exceed 60,000.

Shen Zhengnan mentioned that the BA.1 bivalent vaccine will be administered next week, but there are only a few hundred thousand doses at present, and the elderly will get the first shot, and then the medical staff will come. Many people are waiting for bivalent vaccines now, but if the purchase is slow, the old vaccine can also be used. In fact, the protective power of the old vaccines is not much worse. When the BA.5 bivalent vaccine arrived in Hong Kong, the epidemic had already passed its peak.

Shen Zhengnan said that residents of long-term care and mental institutions should take the fourth dose as soon as possible, which will have protection. Even residents who have been confirmed should continue to be vaccinated if they have passed 3 months, because there is still a risk of reinfection.

Shen Zhengnan explained that the experimental results of high-end as the third dose were high-end news released, saying that compared with mRNA vaccines, there is no statistical difference in the ratio of breakthrough infections. This experiment is a statistics conducted by medical personnel. The breakthrough infection is about 15 to 17%, and the research time is from April to July this year. Some people say that such a report is too brief and does not mean anything. In fact, if the protection is much worse, a very simple study will see the difference. From this, we can see that high-end acting as the third dose may also have a certain amount of protection.